how big is Saptak Chem &?

As of October 2023, Saptak Chem & Business Ltd has a market capitalization of 3.58 Cr, categorized as a Micro Cap company, with recent quarterly net sales of 0.00 Cr and a net profit of -0.08 Cr. The latest balance sheet shows shareholder's funds at -2.17 Cr and total assets of 0.16 Cr.

Market Cap: Saptak Chem & Business Ltd has a market capitalization of 3.58 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters, which includes Mar'25, Dec'24, Sep'24, and Jun'24, is 0.00 Cr. The sum of Net Profit for the same quarters is -0.08 Cr. This data is based on Standalone financials.<BR><BR>Balance Sheet Snapshot: This is based on Standalone data for the latest annual period ending in Mar'24. The Shareholder's Funds are reported at -2.17 Cr, while Total Assets amount to 0.16 Cr.

Who are the top shareholders of the Saptak Chem &?

The top shareholders of Saptak Chem & include Alpha Antibiotics Limited with 12.58%, and Parag Dinesh Sanghvi (HUF) at 8.37%. Individual investors hold 75.01%, with no pledged promoter holdings or involvement from mutual funds or foreign institutional investors.

The top shareholders of Saptak Chem & include Alpha Antibiotics Limited, which holds the highest promoter stake at 12.58%. The highest public shareholder is Parag Dinesh Sanghvi (HUF), with a holding of 8.37%. Additionally, individual investors collectively hold a significant portion of 75.01%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) involved.

What does Saptak Chem & do?

Saptak Chem and Business Ltd, a micro-cap company founded in 1980, trades in agricultural produce and chemicals. As of March 2025, it reported no net profit and has a market cap of Rs 4 Cr, with a P/E ratio of 4.00.

Overview: <BR>Saptak Chem and Business Ltd operates in the trading of agricultural produce and chemicals, belonging to the micro-cap category within the Trading & Distributors industry.<BR><BR>History: <BR>The company was incorporated on March 12, 1980, originally named 'Munak Chemicals Limited', and changed its name to Saptak Chem and Business Limited in November 2017. The latest quarterly results reported are for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: Rs 4 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 4.00 <BR>Industry P/E: 24 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -1.06 <BR>Return on Equity: -0.46% <BR>Price to Book: -1.71<BR><BR>Contact Details: <BR>Address: 3 Mohan Chamber, Beside Post Office Dakor Kheda Kheda Gujarat : 388225 <BR>Tel: +919909996192 <BR>Email: info@saptakchem.com <BR>Website: http://www.saptakchem.com

When is the next results date for Saptak Chem &?

No Upcoming Board Meetings

Who are in the management team of Saptak Chem &?

As of March 2022, the management team of Saptak Chem & includes Manthan Bhavsar (Managing Director), Chirag Nanavati, Bhoomiben Patel, and Sonal Deepalbhai Gandhi (Independent Directors), and Meera Panchal (Company Secretary & Compliance Officer).

As of March 2022, the management team of Saptak Chem & consists of the following individuals:<BR><BR>1. Manthan Bhavsar - Managing Director<BR>2. Chirag Nanavati - Independent Director<BR>3. Meera Panchal - Company Secretary & Compliance Officer<BR>4. Bhoomiben Patel - Independent Director<BR>5. Sonal Deepalbhai Gandhi - Independent Director<BR><BR>These members play key roles in the governance and operational oversight of the company.

Has Saptak Chem & declared dividend?

No Dividend History Available

Who are the peers of the Saptak Chem &?

Saptak Chem &'s peers include Redington, MMTC, MSTC, Ravindra Energy, Chambal Brewer, and Diksha Greens. Redington shows excellent management and growth, while Ravindra Energy has the highest 1-year return at 142.31%, and Saptak Chem & has a 1-year return of -3.48%.

Peers: The peers of Saptak Chem & are Redington, MMTC, MSTC, Ravindra Energy, Chambal Brewer, and Diksha Greens.<BR><BR>Quality Snapshot: Excellent management risk is observed at Redington, while Average management risk is found at MMTC and MSTC. Below Average management risk is present at Ravindra Energy, and the rest do not qualify. Growth is Excellent at Redington, Below Average at MMTC and MSTC, and Below Average at Ravindra Energy, with the rest not qualifying. Capital Structure is Good at Redington, Excellent at MSTC, and Below Average at Ravindra Energy, while the rest do not qualify.<BR><BR>Return Snapshot: Ravindra Energy has the highest 1-year return at 142.31%, while MSTC has the lowest at -39.77%. Saptak Chem & has a 1-year return of -3.48%, which is better than MSTC but worse than Ravindra Energy. Additionally, MSTC and Chambal Brewer have negative six-month returns.

What is the technical trend for Saptak Chem &?

As of June 5, 2025, Saptak Chem's trend is mildly bullish in the short term, but longer-term indicators show mixed signals with bearish tendencies on the weekly and monthly charts.

As of 5 June 2025, the technical trend for Saptak Chem & has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages indicating a positive trend. However, the weekly MACD is bearish and the monthly MACD is mildly bearish, suggesting some weakness in the longer time frames. The KST remains bullish on both weekly and monthly charts, which provides some strength to the overall outlook. The Bollinger Bands show a mildly bearish trend on the weekly, while the Dow Theory indicates a mildly bearish stance on the weekly and no trend on the monthly. Overall, the indicators present a mixed picture, with short-term bullishness countered by longer-term bearish signals.

Is Saptak Chem & overvalued or undervalued?

As of September 23, 2025, Saptak Chem & is considered overvalued with a PE ratio of 0.92 and negative financial metrics, despite a 216.97% stock return over the past year, contrasting sharply with its peers.

As of 23 September 2025, the valuation grade for Saptak Chem & has moved from risky to does not qualify, indicating a significant deterioration in its valuation outlook. The company appears to be overvalued based on its current financial metrics, including a PE ratio of 0.92, an EV to EBIT of -3.23, and an ROCE of -9.00%. These figures suggest that the company's earnings and capital efficiency are not aligned with its market price.<BR><BR>In comparison to its peers, Saptak Chem & stands out with a PE ratio of 0.92, while Coromandel International has a PE of 33.48 and Chambal Fertilizers shows a PE of 12.31. This stark contrast highlights Saptak Chem &'s unfavorable position in the market. Additionally, the company has shown a remarkable return of 216.97% over the past year, significantly outperforming the Sensex, which declined by 3.33% during the same period. However, despite this impressive stock performance, the underlying financial ratios indicate that Saptak Chem & is currently overvalued.

How has been the historical performance of Saptak Chem &?

Saptak Chem & has experienced a significant decline in financial performance from 2019 to 2025, with net sales dropping to zero and increasing losses, resulting in negative reserves and shareholder funds. Overall, the company has shown a consistent downward trend in key financial metrics.

Answer:<BR>The historical performance of Saptak Chem & shows a significant decline in financial metrics over the years, particularly from 2019 to 2025.<BR><BR>Breakdown:<BR>Saptak Chem & experienced a notable drop in net sales, with figures decreasing from 3.57 Cr in March 2019 to 0.00 Cr in March 2025. Total operating income followed a similar trend, peaking at 3.57 Cr in March 2019 and falling to 0.00 Cr by March 2025. The company's total expenditure, excluding depreciation, also fluctuated, with a high of 3.50 Cr in March 2019 and a low of 0.09 Cr in March 2025. Operating profit (PBDIT) turned negative, moving from a profit of 0.07 Cr in March 2019 to a loss of 0.09 Cr in March 2025. Profit before tax and profit after tax mirrored this decline, with losses reported in the last two years. The company's reserves have been negative since March 2020, reaching -12.99 Cr in March 2025. Shareholder's funds remained negative, indicating a deteriorating financial position, while total liabilities decreased from 1.59 Cr in March 2019 to 0.16 Cr in March 2024. Overall, Saptak Chem & has seen a consistent decline in performance metrics, culminating in zero revenue and increasing losses in recent years.

Are Saptak Chem & latest results good or bad?

Saptak Chem's latest results are concerning, with an EPS of Rs -0.19 and no growth in net sales or profit compared to last year. MarketsMOJO has issued a 'Sell' call, indicating a need for strategic reassessment.

The latest financial results for Saptak Chem & Business indicate a concerning performance. For the quarter ending September 2025, the company reported an earnings per share (EPS) of Rs -0.19, which is the lowest in the past five quarters. This decline in profitability suggests that the company is generating lower earnings for its shareholders.<BR><BR>Additionally, the net sales and standalone net profit both showed no growth compared to the same quarter last year, remaining at 0.00%. This flat performance, combined with a decrease in the company's score from 0 to -1 over the last three months, has led MarketsMOJO to issue a 'Sell' call on the stock.<BR><BR>Overall, the results reflect a need for strategic reassessment as Saptak Chem navigates its current market challenges.

Should I buy, sell or hold Saptak Chem &?

Why is Saptak Chem & falling/rising?

As of N/A, Saptak Chem & Business Ltd is priced at 14.75, with a notable 391.67% return over the past year, outperforming the BSE500. However, concerns arise from a flat EPS of Rs -0.19, declining promoter stakes, and negative EBITDA, indicating potential financial instability despite strong market performance.

As of N/A, Saptak Chem & Business Ltd is currently priced at 14.75, reflecting an increase of 0.28, or 1.94%. While today's price summary data is unavailable, the stock has demonstrated impressive performance over various periods, including a 391.67% return over the past year, significantly outperforming the market benchmark (BSE500), which returned only 4.72%. However, there are concerns as the company reported a flat EPS of Rs -0.19 for the quarter ending September 25, and its profits have not increased despite the high returns. Additionally, promoter confidence appears to be waning, with a 3.73% reduction in their stake, which may indicate a lack of faith in the company's future prospects.<BR><BR>In the broader market context, Saptak Chem's short-term return of 10.07% over the past week stands in stark contrast to the Sensex, which has declined by 1.38%. This strong performance relative to the benchmark suggests that investor interest in Saptak Chem remains robust despite the underlying risks, such as negative EBITDA and declining promoter stakes. The company's ability to generate substantial returns over the longer term, coupled with recent price increases, indicates a complex situation where positive market performance is tempered by significant financial concerns.

Which are the latest news on Saptak Chem &?